Antibiotic Treatment for Diabetic Foot Infections

Classification and Assessment

The International Diabetes Federation recommends classifying diabetic foot infections as mild, moderate, or severe to guide appropriate antibiotic selection and treatment approach 1, 3
The Infectious Diseases Society of America suggests obtaining appropriate wound cultures before starting antibiotics to guide definitive therapy 2, 4

For mild infections, the American Diabetes Association recommends targeting primarily aerobic gram-positive cocci (Staphylococcus aureus and streptococci) 2
The European Diabetes Foundation suggests using oral options such as dicloxacillin, clindamycin, cephalexin, amoxicillin/clavulanate, and trimethoprim-sulfamethoxazole for mild infections 2, 3
For moderate infections, the Infectious Diseases Society of America recommends broader spectrum coverage, especially with prior antibiotic exposure 2, 3
The American College of Clinical Pharmacy suggests using oral options such as amoxicillin/clavulanate, levofloxacin, and trimethoprim-sulfamethoxazole for moderate infections 2
For severe infections, the Society for Healthcare Epidemiology of America recommends requiring broad-spectrum parenteral antibiotics initially 2, 3
The International Diabetes Federation suggests using recommended options such as piperacillin/tazobactam, imipenem-cilastatin, vancomycin plus ceftazidime, and levofloxacin or ciprofloxacin with clindamycin for severe infections 2

The American Diabetes Association recommends considering MRSA coverage if risk factors are present or local prevalence is high 2
The Infectious Diseases Society of America suggests not empirically targeting Pseudomonas aeruginosa in temperate climates unless it has been isolated from cultures of the affected site within previous weeks or in patients with moderate/severe infection who reside in Asia or North Africa 1, 4

The European Diabetes Foundation recommends administering antibiotics for 1-2 weeks for most skin and soft tissue diabetic foot infections 1, 4
The American College of Clinical Pharmacy suggests considering continuing treatment for up to 3-4 weeks if infection is extensive or resolving slower than expected, or if patient has severe peripheral artery disease 1, 4
The Infectious Diseases Society of America recommends considering up to 3 weeks of antibiotic therapy after minor amputation with positive bone margin culture for osteomyelitis 4
The Society for Healthcare Epidemiology of America suggests considering 6 weeks for osteomyelitis without bone resection or amputation 4

The American Diabetes Association recommends assessing response to therapy regularly - daily for inpatients and every 2-5 days initially for outpatients 2
The International Diabetes Federation suggests using primary indicators of improvement such as resolution of local and systemic symptoms and clinical signs of inflammation 2
The Infectious Diseases Society of America recommends re-evaluating and considering further diagnostic studies or alternative treatments if infection has not resolved after 4 weeks of appropriate therapy 1, 4
The European Diabetes Foundation suggests using outcome at minimum follow-up of 6 months after end of antibiotic therapy to diagnose remission of osteomyelitis 4